Australia To Fund Bionic Eye Research For Lost, Impaired Vision
This article was originally published in PharmAsia News
Executive Summary
Australia said it would contribute U.S.$35 million toward research into development of a prosthesis to restore or enhance vision in people with impairments. Prime Minister Kevin Rudd said the commitment to developing a "bionic eye" was important because millions of Australians have impaired vision and the technology gained might be adapted to other areas of need. The prosthetic eye envisioned would be able to restore lost vision or amplify existing vision. (Click here for more
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.